Answers are grounded in this paper and cite their sources.
Sixty-nine percent of cancer prevention and screening recommendation statements either did not quantify benefits and harms or presented them in an asymmetric manner. Improved presentation of benefits and harms in guidelines would better ensure that clinicians and patients have access to the information required for making informed decisions.
No takes yet. Share an insight, caveat, or question.
Caverly et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: